CRISPR Therapeutics AG

Senior Scientist, Oligonucleotide

CRISPR Therapeutics AG$145K — $155K *
Pharmaceuticals & Biotech
Less than 5 years of experience
Job Overview by Ladders

Qualifications

  • Ph.D. in Organic or Medicinal Chemistry or related discipline with 4.5-8+ years of experience; or non-PhD with 12-15 years of relevant experience.
  • Extensive knowledge of phosphoramidite chemistry and nucleotide modifications.
  • Direct experience with automated oligonucleotide synthesizers and purification systems.
  • Proficiency in troubleshooting mass spectrometry data for complex macromolecules.
  • Familiarity with ICH guidelines and cGMP manufacturing environments is preferred.

Responsibilities

  • Lead the design and execution of automated solid-phase synthesis of modified oligonucleotides.
  • Develop and optimize purification processes using advanced techniques.
  • Oversee and perform structural elucidation and purity assessments of oligonucleotides.
  • Drive optimization of synthetic routes and methodologies for improved yields.
  • Evaluate and implement novel chemical modifications and delivery technologies.
  • Serve as oligochemistry lead on project teams, guiding research efforts.
  • Supervise and mentor junior scientists, maintaining detailed laboratory documentation.

Benefits

  • Collaborative work environment promoting mentorship and growth.
  • Opportunities to lead cross-functional projects on innovative oligonucleotide technologies.
  • Involvement in clinical development, contributing to cutting-edge research.
  • Potential for equity and performance bonuses, enhancing overall compensation package.
Full Job Description

Job Description:

Position Summary

We are seeking a highly skilled and motivated Senior Oligonucleotide Scientist to join our non-viral delivery (NVD) technical development team. In this role, you will serve as a technical lead in the design, synthesis, purification and analysis of modified oligonucleotides. You will drive the innovation in chemical modifications, scale-up process development and optimizations to support our advancing pipelines from early-stage research and discovery through clinical development.

The ideal candidate possesses deep expertise in solid-phase synthesis, state of the art purification techniques, and analytical characterization, combined with a proven track record of mentoring junior scientists, leading cross-functional projects.

Responsibilities

  • Synthesis & Modification: Lead the design and execution of automated solid-phase synthesis of complex, highly modified oligonucleotides at various scales.
  • Purification & Downstream Processing: Develop and optimize robust purification processes using preparative RP-HPLC, IEX and SEC, as well TFF and lyophilization.
  • Analytical Characterization: Oversee and perform comprehensive structural elucidation and purity assessments using LC-MS, MALDI-TOF, NMR, and capillary electrophoresis.
  • Process Development & Scale-Up: Drive the optimization of synthetic routes and cleavage/deprotection methodologies to improve yields, reduce impurities, and ensure scalable, reproducible processes.
  • Innovation & R&D: Evaluate and implement novel chemical modifications, conjugation strategies (e.g., GalNAc, lipids, peptides), and delivery technologies to enhance oligonucleotide stability and potency.
  • Project Leadership: Serve as the oligochemistry lead on multidisciplinary project teams.
  • Mentorship & Documentation: Supervise, mentor, and train junior chemists and laboratory technicians. Maintain meticulous laboratory notebooks, write SOPs, and contribute to regulatory filings.
  • Lab Operations: Manage inventory of oligonucleotides testing articles as well as critical reagents and phosphoramidites for Oligo Synthesis and purification.
  • Scientific Communications: Analyze, interpret, and organize data to prepare experimental reports and communicate the results of the projects at internal and external meetings.

Minimum Qualifications

  • A Ph.D. in Organic Chemistry, Medicinal Chemistry or a closely related discipline with 4.5-8+ years of experience and minimum of 2 years industrial biopharma/biotech experience OR non-PhD with 12-15 years of progressive, relevant experience.
  • Deep understanding of phosphoramidite chemistry, protecting group strategies, and nucleotide modifications (e.g., 2'-OMe, 2'-F, phosphorothioates, locked nucleic acids).
  • Hands-on experience with automated oligonucleotide synthesizers (e.g., Cytiva KTA Oligopilot, Mermade, etc.) and preparative purification systems.
  • Strong background in troubleshooting and interpreting mass spectrometry (LC-MS) data for complex macromolecules.
  • Familiarity with ICH guidelines and cGMP manufacturing environments is highly desirable.

Preferred Qualifications

  • Strong problem-solving skills and the ability to thrive in a fast-paced, matrixed environment.
  • Excellent written and verbal communication skills for presenting data to both technical and non-technical stakeholders.
  • Proven ability to lead projects and foster a collaborative team environment.

Competencies

  • Collaborative Openness, One Team
  • Undaunted Fearless, Can-do attitude
  • Results Orientation Delivering progress toward our mission. Sense of urgency in solving problems.
  • Entrepreneurial Spirit Proactive. Ownership mindset.

Due to the nature of their work, our manufacturing and lab-based positions are located fully on-site.

Senior Scientist, Oligonucleotide: Base pay range of $145,000 to $155,000+ bonus, equity and benefits

The range provided is CRISPR Therapeuticsreasonable estimate of the base compensation for this role. The actual amount will be based on job-related and non-discriminatory factors such as experience, training, skills, and abilities.

About CRISPR Therapeutics AG

CRISPR Therapeutics AG, a gene editing company, focuses on developing transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 gene-editing platform. The company develops its products through in-house research programs and partnerships with biopharmaceutical companies and academic researchers. Its lead product candidate is CTX001, an ex vivo CRISPR gene-edited therapy for treating patients suffering from transfusion-dependent beta thalassemia or severe sickle cell disease in which a patient's hematopoietic stem cells are engineered to produce high levels of fetal hemoglobin in red blood cells. The company was formerly known as Inception Genomics AG and changed its name to CRISPR Therapeutics AG in April 2014. CRISPR Therapeutics AG was founded in 2013 and is headquartered in Zug, Switzerland.
Learn more about CRISPR Therapeutics AG
Size
473 employees
Market Cap
$3.3 billion
Industry
Net Income
-$348.8 million
Founded
2013
5 Year Trend
+181.6%
Revenue
$720,000
NASDAQ

Similar Jobs

More Jobs at CRISPR Therapeutics AG

More Pharmaceuticals & Biotech Jobs

Find similar Senior Scientist, Oligonucleotide jobs: